Cite
HARVARD Citation
Oliveira, M. et al. (2019). FAIRLANE, a double-blind placebo-controlled randomized phase II trial of neoadjuvant ipatasertib plus paclitaxel for early triple-negative breast cancer. Annals of oncology. pp. 1289-1297. [Online].